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50%.3-7 These figures are all the more alarming when
the potential impact both to the individual and to soci-
ety are considered. Individual cost (in terms of lost per-
sonal potential) and societal cost (measured in resource
usage) may accrue over decades after a neonatal brain
injury.
Because of these concerns, we have developed a tech-
nique of regional perfusion during neonatal aortic arch
reconstruction.8 Guided by near-infrared spectroscopy
(NIRS), this technique drastically reduces circulatory
arrest time and maintains cerebral blood volume and
oxygen saturation while providing the same surgical
exposure obtained during DHCA. We report our experi-
ence using this technique in 6 neonates who underwent
extensive aortic arch reconstructions.
Methods
Surgical technique. Six children underwent neonatal aortic
arch reconstruction with regional low-flow perfusion (RLFP)
(Table I). In these children, standard arch reconstruction was
performed with minor modifications. On initiation of car-
diopulmonary bypass through the ductus arteriosus (through
the pulmonary artery) and the right atrial appendage, the
patient is cooled to 18°C. The ductus is snared around the
arterial cannula, and preparatory dissection is performed. This
T he use of deep hypothermia and circulatory arrest(DHCA) in children who have undergone complex
aortic arch reconstruction has been considered unavoid-
able. Although the duration of safe DHCA remains
unknown, 30 to 45 minutes is considered the upper
limit.1,2 We know from our transplantation experience
that many organs will tolerate several hours of cold
ischemia; however, the brain does not. Evidence of
overt brain injury may be found in up to 10% of chil-
dren who have undergone DHCA, although subtle but
detectable neuropsychiatric injuries may occur in up to
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REGIONAL LOW-FLOW PERFUSION PROVIDES CEREBRAL CIRCULATORY SUPPORT DURING
NEONATAL AORTIC ARCH RECONSTRUCTION
includes the aortic arch, extending distal to ductal insertion,
and the brachiocephalic vessels. The innominate artery is
controlled at its bifurcation into the right common carotid and
subclavian arteries, and the proximal anastomosis of the
anticipated modified Blalock shunt is performed (3.5-mm
polytetrafluoroethylene*). The shunt is left long and clamped.
Cardiopulmonary bypass is halted; the brachiocephalic ves-
sels are snared, and the patient’s blood is exsanguinated into
the reservoir. The arterial and venous cannulas are removed,
and the atrial septectomy is performed through the atrial
appendage. At this time, the arterial cannula is inserted into
the shunt and, after careful deairing, tied into position. With
the right common carotid artery temporarily occluded to
avoid air embolism, RLFP is initiated at 5 mL · kg–1 · min–1
and increased every 2 to 3 minutes until cerebral blood vol-
ume has reached precirculatory arrest levels. A small metal-
tipped bullet sucker placed through the atrial appendage scav-
enges blood returning to the heart (Fig 1). The remainder of
the arch reconstruction was performed at 18°C under condi-
tions of RLFP. A bloodless operative field is maintained by
the brachiocephalic snares, the right atrial scavenger, and a
small angled crossclamp on the descending aorta. The pur-
pose of the crossclamp is 2-fold: By elevating the distal-most
portion of the reconstruction, visualization and access are
improved, and back bleeding from the descending aorta is
prevented. On completion of arch reconstruction, the neoaor-
ta and right atrial appendage are recannulated, and full car-
diopulmonary bypass is resumed.
Control patients. Six patients who underwent heart
surgery with DHCA for a variety of congenital heart condi-
tions were also studied with NIRS (Table I).
Anesthetic and perfusion management. Anesthetic and
cardiopulmonary bypass management was standardized and
was the same for both groups of patients. Anesthetic tech-
nique was consistent and used high-dose opiates for all
patients. During cooling, cardiopulmonary bypass flow was
maintained between 2.0 and 2.5 L · min–1 ˙ m–2 to achieve a
rectal temperature of 18°C. Blood gas management was by
the alpha-stat technique.
Monitoring. Standard hemodynamic monitoring was
applied to all children. Arterial blood pressure was monitored
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Table I. Demographics
Patients Weight (kg) Age Diagnosis CAT (min) RLFP (min)
With RLFP
1 2.4 7 d Aortic valve atresia, VSD, aortic hypoplasia 6 58
2 3.5 5 d D-TGA, hypoplastic right ventricle, VSD, 6 41
aortic hypoplasia
3 2.1 7 d HLHS 10 47
4 3.4 5 d HLHS 7 49
5 3.1 3 d HLHS 9 49
6 3.6 4 h HLHS, restrictive atrial septum 17 52
Mean (±SD) 3 (.6) 9 (4) 49 (6)
Without RLFP
1 4.4 5 d L-TGA, hypoplastic right ventricle 59 NA
2 4.1 240 d PAPVR intrathoracic kidney, pulmonary 26 NA
sequestration
3 3.1 4 d HLHS 60 NA
4 3.5 7 d D-TGA, VSD 9 NA
5 5.5 100 d VSD 32 NA
6 2.8 2 d TAPVR 40 NA
Mean (±SD) 3.9 (1) 38* (20)
CAT, Circulatory arrest; VSD, ventricular septal defect; TGA, transposed great arteries; NA, not applicable; PAPVR, partial anomalous pulmonary venous return;
TAPVR, total anomalous pulmonary venous return. 
*P = .006.
Table II. Change in CrBVI and CrSO2 during RLFP or circulatory arrest as compared with baseline values
N Circulatory arrest (min) ∆CrSO2 ∆CrBVI
With RLFP 6 9 ± 4 (6-17) –0.8 ± 5.26 –1.4 ± 2.7
Without RLFP 6 38 ± 20* (9-60) –33.5 ± 14.6† –19.2 ± 14.3‡
∆CrSO2, Change in relative CrSO2 from baseline; ∆CrBVI, change in relative CrBVI from baseline. Values are mean ± SD. Numbers in parenthesis are ranges. 
*P = .006.
†P = .002.
‡P = .03.
*Gore-Tex conduit, registered trademark of W. L. Gore & Associates,
Inc, Flagstaff, Ariz.
by a left radial artery catheter. Rectal and esophageal temper-
ature probes were inserted for temperature management.
After informed consent was obtained, all children underwent
intraoperative monitoring of relative cerebral blood volume
index (CrBVI) and oxygen saturation (CrSO2) with NIRS
(INVOS 4100; Somanetics Corp, Troy, Mich; NIRO 500;
Hamamatsu Phototomics, Hamamatsu, Japan). A sensor
placed on the right lateral forehead monitored CrSO2 and
CrBVI. Relative CrBVI and percent oxyhemoglobin satura-
tion were displayed in real time, and these data were used to
direct the rate of RLFP. Data were downloaded and stored for
later analysis.
Data acquisition. Standard hemodynamic monitoring was
applied to all patients. Patients who underwent DHCA with-
out RLFP served as control subjects, and CrBVI and CrSO2
were compared with those of neonates who underwent aortic
arch reconstruction with RLFP. Arterial blood pressure was
obtained through a left radial arterial line. After the induction
of anesthesia and before the draping of the patient, NIRS sen-
sors were placed over the right frontoparietal area of the
brain. Data were sampled every 2 seconds and saved to disk.
Data acquisition began with sensor placement and ended with
patient transport to the intensive care unit. Baseline CrBVI
and CrSO2 were obtained after the institution of full car-
diopulmonary bypass support and after core cooling but
before circulatory arrest or RLFP. Data in Table II are pre-
sented as change in CrBVI (∆CrBVI) and CrSO2 (∆CrSO2)
during RLFP or circulatory arrest as compared with baseline
values. Percent return to baseline was measured when both
relative CrBVI and CrSO2 stabilized on RLFP.
Statistical analyses were done by analysis of variance for
repeated measures for normally distributed data and the
Tukey procedure for significant differences. Values presented
are mean ± standard deviation unless otherwise stated.
Results
There were no deaths in either group of patients.
Mean duration of RLFP was 49 ± 6 minutes (range, 41-
58 minutes), and there were no complications related to
RLFP. With RLFP, a short period of DHCA is required
for decannulations, recannulations, and atrial septecto-
my when necessary. This time, however, is very brief
and consistent (9 ± 4 minutes) and was significantly
shorter than that required by the children in the control
group. Furthermore, the children who underwent
DHCA demonstrated a significantly greater fall in both
relative CrBVI (∆CrBVI) and CrSO2 (∆CrSO2) as
compared with patients whose condition was supported
with RLFP (Table II).
Because of concerns about cerebral hyperperfusion,
we used real-time NIRS data to gradually increase the
rate of RLFP until CrBVI was restored to baseline lev-
els (obtained on full cardiopulmonary support).
Restoration of baseline CrBVI consistently occurred
with a RLFP rate of 20 mL · kg–1 · min–1. Furthermore,
with the restoration of CrBVI, CrSO2 was also restored to
baseline values (Fig 2). This is in contrast to children in
the control group who experienced a prompt and pre-
dictable decline in both CrBVI and CrSO2 (Figs 3 and 4).
During the brief period of circulatory arrest required
for atrial septectomy and recannulation, radial artery
pressure was 0 mm Hg. With RLFP and the restoration
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Fig 1. Depiction of the operative field during aortic arch
reconstruction with RLFP. Arterial inflow is through the can-
nulated shunt after the anastomosis to the innominate artery
is performed. Exposure is maintained by the brachiocephalic
snares, a clamp on the descending aorta, and the right atrial
blood scavenger. The 3.5-mm polytetrafluoroethylene graft
will admit an 8F or 10F arterial cannula (Medtronic Bio-
Medicus, Eden Prairie, Minn). On completion of the neoaor-
ta, deairing is accomplished by removing the aortic clamp.
Fig 2. Relative CrBVI and relative CrSO2 as a function of
RLFP rate. Reacquisition of baseline CrBVI () occurs con-
sistently at about 20 mL · kg–1 · min–1, and is mirrored by
return to baseline CrSO2 ().
of baseline CrBVI and CrSO2, the left radial artery
catheter measured an average of 22 mm Hg (16-28
mm Hg).
Discussion
Because operative death rates for congenital heart
defects have declined, concern has focused on the neu-
rologic consequences of operations for congenital heart
disease. Ferry9 has reported that up to 25% of infants
who underwent cardiac surgery with hypothermic car-
diopulmonary bypass had some form of neuropsychi-
atric injury. Concern escalates when circulatory arrest
is added to hypothermic cardiopulmonary bypass.
Citing autopsy evidence, Glauser and colleagues10
reported neurologic injury in 10 of 13 patients (77%)
who underwent DHCA for hypoplastic left heart syn-
drome (HLHS). These injuries included cerebral necro-
sis, periventricular leukomalacia, brain stem necrosis,
and intracranial hemorrhage. They found that brain
injury was associated with DHCA times that exceeded
40 minutes. In an effort to further define the incidence
and magnitude of neuropsychiatric injury that resulted
from DHCA in a clinical setting, Newberger and col-
leagues11 studied the effects of DHCA versus low-flow
cardiopulmonary bypass in 171 infants who were
younger than 3 months of age. They also found that
DHCA resulted in neuropsychiatric injury, manifested
by an increased propensity for perioperative seizures
and long-term psychomotor and cognitive impairment
and that this impairment was related to the duration of
DHCA.
Thus although DHCA may be a valuable technique,
efforts to limit the duration of DHCA are necessary.
Although the safe duration of DHCA is unclear, most
clinical and experimental evidence suggests that
hypothermia (16°C-18°C) provides adequate neuropro-
tection for 30 to 45 minutes.1,12,13 Although this dura-
tion may appear to be well tolerated, the studies that are
cited reinforce a compelling intuitive desire to reduce
DHCA time to an absolute minimum. Reports explor-
ing the minimum circulatory requirements of the brain
supported by cardiopulmonary bypass suggest that low
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Fig 3. NIRS. Depicts relative CrSO2 in 2 infants. The first is a 3.1-kg 5-day-old infant who underwent a Norwood
operation for HLHS (heavy line). The second neonate (thin line) is a 2-day-old infant who underwent a repair of
total anomalous pulmonary venous return under circulatory arrest. Although the rate of desaturation between the
2 patients is similar, the institution of RLFP in the neonate who underwent the Norwood operation restores CrSO2
to baseline levels. Sharp declines in CrSO2 in the hypoplast on RLFP at circulatory arrest (CA) and cardiopul-
monary bypass (CPB) correlate with decannulation and atrial septectomy and with recannulation after recon-
struction of the neoaorta. 40, Initiation of RLFP at 40 mL/min; 50, 50 mL/min; 60, 60 mL/min.
flow is better than no flow; common sense dictates that
less circulatory arrest time is better than more.11,14
With this in mind, alternatives to DHCA have been
sought. Asou and colleagues15 and Sano and col-
leagues16 have described a similar technique but pro-
vided no data to support the contention that the brain
was sustained. McElhinney and colleagues17 described
technical modifications that minimize DHCA duration
in infants undergoing the Damus-Kaye-Stansel proce-
dure. This recent interest in alternatives to DHCA
underscores a growing awareness that neurologic
injury is a serious concern during heart surgery in
neonates and infants. Although much time and effort
have been directed toward developing strategies to
minimize the neurologic injury associated with DHCA,
we suggest the simplest and most direct strategy is to
minimize exposure to the insult as much as possible.
RLFP accomplishes this goal by providing cerebral
circulatory support and greatly reducing the duration of
DHCA required for neonatal arch reconstruction. This
already brief (average, 9 minutes) duration may be
reduced even further by the initiation of cardiopul-
monary bypass through the shunt. We have no experi-
ence with this modification but are concerned about the
potential for cerebral hyperperfusion and somatic
hypoperfusion in the presence of a diminutive aorta,
particularly at normothermia.
NIRS is a recent, noninvasive technology capable of
measuring changes in tissue chromophores, such as
hemoglobin.18 NIRS exploits the differences in absorp-
tion peaks between oxygenated and deoxygenated
hemoglobin and provides information on the changes,
or relative differences, in these compounds over time.19
Again, these are relative changes; absolute values re-
quire the measurement of the path length of the NIRS
signal, which is not readily available with current tech-
nology. The relative CrBVI and CrSO2 are mainly
determined by the cerebral venous blood because it
comprises about 75% of intracranial blood volume
(arterial, approximately 20%; capillaries, approximate-
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Fig 4. CrBVI, NIRS data. Depicts relative CrBVI in same 2 infants (HLHS with RLFP [heavy line]; total anom-
alous pulmonary venous return with circulatory arrest [thin line]). RLFP restores relative CrBVI to near baseline
levels, although CrBVI remains depressed in the neonate who underwent circulatory arrest. As with relative
CrSO2, sharp declines in CrBVI in the hypoplast on RLFP occurring at circulatory arrest (CA) and cardiopul-
monary bypass (CPB) correlate with decannulation and atrial septectomy and recannulation after construction of
the neoaorta. 40, initiation of RLFP at 40 mL/min; 50, 50 mL/min; 60, 60 mL/min.
ly 5%).20 However, there is a strong clinical correlation
between the NIRS signal and flow in the internal
carotid artery, and NIRS has been used in neonatologic
procedures and in pediatric heart surgery.21-23
The use of NIRS technology has guided our RLFP
rate and enabled us to document that regional perfusion
of the brain provides the same CrBVI and CrSO2 that
are provided by standard cardiopulmonary bypass sup-
port. Although data defining the lower limit of blood
flow to the human neonatal brain are not available, our
finding that 20 mL · kg–1 · min–1 RLFP is required for
CrBVI and CrSO2 restitution is consistent with animal
studies. Using a dog model, Miyamoto and col-
leagues24 concluded that the optimal perfusion rate for
the brain at 20°C was 30 mL · kg–1 · min–1, with oxy-
gen debt and anaerobic metabolism when flow rate was
less than 15 mL · kg–1 · min–1. In sheep, Swain and col-
leagues25 showed preservation of energy substrates
with flows as low as 10 mL · kg–1 · min–1. Because of
concerns about cerebral hyperperfusion with the use of
RLFP, we believed it appropriate to limit the perfusion
rate such that baseline CrBVIs (measured by NIRS on
full-flow hypothermic cardiopulmonary bypass) were
maintained. In this way NIRS allows us, for the first
time, to quantify blood flow requirements of the neona-
tal brain at hypothermic temperatures. Thus for the
human neonate, the data suggest that 20 mL · kg–1 ·
min–1 (delivered with this technique and using alpha-
stat blood gas management) provides adequate cerebral
circulatory support.
This is an important qualification because we did not
quantify the flow distribution (ie, right subclavian vs
right common carotid arteries) during RLFP. Flow dis-
tribution will depend on the relative resistances in the
perfused vascular beds. Although it has been shown
that cerebral vascular resistance increases with
hypothermia, systemic vascular resistance can be
expected to increase even more.26 Thus we believe that
most of the RLFP preferentially enters the cerebral cir-
culation and that intracranial and extracranial arterial
collateral connections between the head the left radial
artery are required to explain a left radial arterial pres-
sure of 22 mm Hg. Furthermore, our observation of
substantial back bleeding from the descending thoracic
aorta leads us to speculate that RLFP provides some
degree of somatic circulatory support in addition to
cerebral support. This finding presumably results from
an extensive network of arterial collaterals between the
upper body and the descending aorta in the neonate.
This degree of collateralization is apparent clinically by
the low incidence of paraplegia encountered in neona-
tal coarctation repair.27 These collaterals would include
not only intracranial connections through the circle of
Willis but also extracranial arteries, vertebral arteries,
internal thoracic arteries, and intercostal arteries.
Somatic perfusion through these collaterals may serve
to attenuate the metabolic burden of DHCA, placing
neonates in a better physiologic position to tolerate the
postoperative period. Although RLFP under DHCA
may increase edema formation, we have not identified
this as a clinical problem. Indeed, despite a low thresh-
old for leaving the sternum open after a stage I
Norwood operation, this was required in only 1 of 4
patients who were palliated for HLHS. These findings
deserve further investigation because circulatory sup-
port of the subdiaphragmatic viscera may impart a sig-
nificant survival advantage.
Although extensive neonatal aortic arch reconstruc-
tion may be required in a variety of conditions, it is
most commonly performed in stage I Norwood opera-
tion for HLHS.28,29 It is in this group of patients that
important secondary benefits of RLFP should be rec-
ognized. By supporting the brain during construction
of the neoaorta, the time allowed for the performance
of a technically precise reconstruction is extended. This
is a critically important point because the success of the
Norwood operation hinges on the achievement of 3 sur-
gical goals:
1. Maintainence of satisfactory coronary perfusion
2. Unobstructed and hemostatic construction of the
neoaorta
3. Appropriate pulmonary blood flow
The importance of achieving these goals has been
illustrated by Bertram and colleagues,30 who reviewed
the autopsy results in 122 patients who died after a
Norwood operation. They found that 27% of the deaths
were from impaired coronary perfusion, 14% of the
deaths were from neoaortic obstruction, 7% of the
deaths were from bleeding, and 36% of the deaths were
from inappropriate (excessive or inadequate) pul-
monary blood flow. Allowing more time for the metic-
ulous construction of the neoaorta, without the pressing
need to limit circulatory arrest time, should make these
goals more attainable.
As with HLHS, neonates who undergo complex aor-
tic surgery resulting in biventricular repair may also be
expected to benefit. This was in fact the case for patient
1 (Table I), who was born with aortic valve atresia, aor-
tic hypoplasia, and a large ventricular septal defect
with a satisfactory left ventricle. This child underwent
a Norwood-type reconstruction of the aorta, baffling of
the ventricular septal defect to the neoaorta, and homo-
graft reconstruction from the right ventricle to the pul-
monary arteries. Thus RLFP may extend the surgeon’s
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capabilities when dealing with a variety of aortic patho-
logic conditions.
In summary, RLFP represents a new bypass manage-
ment technique that significantly reduces the exposure
of the neonatal brain to circulatory arrest during aortic
arch reconstruction. This technique is simple and, based
on the NIRS data, provides cerebral circulatory support
equivalent to that provided by full-flow cardiopul-
monary bypass. Furthermore, initial observations sug-
gest that RLFP may provide some degree of somatic cir-
culatory support as well. The reduction of DHCA time
required for neonatal aortic arch reconstruction can be
expected to reduce the risk of cognitive and psychomo-
tor deficits and may reduce perioperative deaths.
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Discussion
Dr Frank Hanley (Berkeley, Calif). This is a very impor-
tant manuscript, not because it describes a new technique; it
does not. Asou and associates, in The Annals of Thoracic
Surgery, described regional cerebral perfusion via a polyte-
trafluoroethylene graft for repair of complex arches in 1996.
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It is also not because this experience is particularly large or
comprehensive. In 1997 our group presented repair of com-
plex neonatal arches without circulatory arrest at the meeting
of The American Association for Thoracic Surgery (AATS)
and then subsequently published it in The Journal of Thoracic
and Cardiovascular Surgery. This experience was subse-
quently updated at the AATS meeting last year with our expe-
rience in 80 infants in whom we used techniques that were
similar to yours, but not identical. About half of those patients
had HLHS. 
There are two reasons why the manuscript is important.
First, it addresses an evolving and controversial topic in con-
genital heart disease: Should DHCA continue to be used in
repair of congenital heart disease? Some historical perspec-
tive is important here. Thirty years ago the pioneer surgeons
who were developing cardiac surgery for neonates and infants
used DHCA as a necessary and unavoidable adjunct to com-
plex procedures in small infants. At that time, equipment,
microsurgical technique, and experience did not allow any
alternatives. As an aside, to emphasize this point we can look
at the arterial switch operation. It is clear that the concept of
that operation had been known for decades, but it was not
until 1980 that a successful arterial switch was performed for
transposition in neonates. The limitation was technical.
Similarly, technical limitations in past decades regained the
use of DHCA to achieve success in small infants. DHCA as a
result was taught by the masters to the subsequent generation
of pediatric heart surgeons, many of whom have simply
accepted the fact that this practice was a necessary compo-
nent of neonatal and infant repair. Even though the risks relat-
ed to DHCA have been well documented, many surgeons
consider this technique to be mandatory or at least preferred,
especially in arch repair. This may have been true 30 years
ago, but no longer is this technique necessary to repair even
the most complex arch reconstructions.
The brain has evolved with its profound complexity over
millions of years. It seems that it is a somewhat misplaced
effort to spend millions in research money, not to mention the
intellectual effort, in figuring out ways to reverse the pro-
found physiologic and biochemical derangements induced by
purposeful brain ischemia. Free radical spin traps and excita-
tory amino acid inhibitors are really only the tip of the iceberg
in solving this very complex problem. 
Why create a very complex problem using DHCA and
then be faced with the profound additional problem of figur-
ing out a way of solving it, when the problem itself can be
completely avoided by eliminating the brain ischemia com-
pletely? It would seem that if a fraction of the money and
research effort that have been put into studying ways to out-
smart brain ischemia were put into developing relatively
simple plumbing techniques of providing reliable continuous
cerebral blood flow, we would solve this problem in a frac-
tion of the time. DHCA is not necessary in modern practice,
and it becomes clear that the research effort in brain
ischemia, at least as it pertains to the practice of cardiac
surgery, has been misplaced if we accept this fact. The cur-
rent emphasis on outsmarting brain ischemia only makes
sense if DHCA is absolutely necessary, and as you have
shown in this study, it is not.
Old comfortable habits die hard. DHCA is comfortable and
easy for many surgeons. This manuscript, therefore, repre-
sents an important addition to the growing number of groups
moving away from DHCA, and you should be congratulated
for this effort.
The second reason why this manuscript is important is that
it is the first study that actually attempts to quantify cerebral
blood flow and cerebral metabolism using continuous region-
al perfusion techniques. These data are badly needed to doc-
ument the efficacy of the technique and to stimulate appro-
priate modifications of the technique as we move ahead.
I have three questions for you. First, your method of can-
nulating the pulmonary artery first and then switching to the
polytetrafluoroethylene graft seems somewhat redundant.
Why don’t you simply put the graft on first, cannulate it, and
perfuse continuously? You would not have to perform even a
brief period of circulatory arrest.
Dr Pigula. Thank you for your comments. The reason we
have done that is to simplify the technique. As you rightly
pointed out, Asou and his associates did describe a technique
similar to this. Although they did not provide any saturation
data, they did provide some pressure data. In their technique
they used two separate cannulations. For the sake of expedi-
ency and simplicity, we use one cannula and simply move it,
accepting a brief period of circulatory arrest.
Dr Hanley. At least in patients undergoing the Norwood
procedure, the arches rarely are truly interrupted, and I can
say our technique is to directly cannulate into the head ves-
sels with a very small arterial cannula, either the base of the
innominate or the carotid artery, and perfuse that way right
from the very beginning. We get excellent cooling using mul-
tiple temperature probes placed on different regions of the
body. It is just another way to do it. 
The second question relates to your method of document-
ing blood flow and metabolism. I, and possibly others, am not
particularly familiar with the method and limitations of cere-
bral NIRS. Does it matter that you put the sensor lateralized
to one side of the brain? Detractors of this technique may say
that if you are perfusing the right side and you have your sen-
sor on the right side, despite flow through the circle of Willis,
the left side of the brain may be in danger. Does this method
globally average the entire brain or is it biased to the side on
which you put the sensor? Should you put the sensor on the
other side? Should you be using tympanic membrane probes
in both ears to see if there are shifts in temperature to obtain
quantitative regional data?
Dr Pigula. That is a very good point. What we are mea-
suring is a regional reflection of cerebral saturations and
blood volume. Therefore, the answer is, yes, we should at
least investigate what the results would be, for instance, on
the left frontoparietal area. I suspect they are going to be the
same, but I have not proven that. 
Dr Hanley. Are you considering doing this in other arch
338 Pigula et al The Journal of Thoracic and
Cardiovascular Surgery
February 2000
problems that have two ventricles, such as interrupted aortic
arch and other complex arch reconstructions?
Dr Pigula. Yes. Actually one of the patients in this report
underwent biventricular repair. One of those patients was a
neonate with aortic atresia and a hypoplastic arch just like a
typical patient with HLHS; however, that baby had a left ven-
tricle with a ventricular septal defect, and we did use this
technique to do a biventricular repair at 8 days of age. I think
it is justified under those circumstances in the face of a very
complex aortic arch reconstruction necessitating a long peri-
od of DHCA.
Dr Christo Tchervenkov (Montreal, Quebec, Canada).
As someone who also does quite a bit of neonatal aortic arch
reconstruction, particularly in complex two-ventricle hearts, I
endorse this trend away from DHCA. However, at the
Montreal Children’s Hospital we have gone in that direction
a lot more cautiously than Dr Hanley’s group has, for a num-
ber of reasons. DHCA was important historically in allowing
pioneer surgeons to finally accomplish neonatal repairs and
improve the survival of these patients. I believe that one of
the most important determinants for survival and also for
brain protection is the achievement of a complete and accu-
rate anatomic repair. Therefore embracing surgical tech-
niques that avoid circulatory arrest must not be done at all
costs if they compromise the accuracy of the intracardiac
repair or if those techniques might result in anatomic stenoses
of the cerebral vessels.
In patients other than those with HLHS, we have placed the
aortic cannula in the ascending aorta at the base of the innom-
inate artery. At the time of doing the aortic arch repair, we
advance the cannula without taking it out into the innominate
artery for regional perfusion, while the aortic arch is repaired,
and then pull it back into the ascending aorta for the rest of the
operation, again without taking it out. Do you have any expe-
rience with the technique I just described in lesions other than
HLHS?
Dr Pigula. No, sir, I do not.
Dr Tchervenkov. We have to be very cautious about direct
cannulation of the innominate artery because of the possibil-
ity of causing significant stenosis in these small vessels in
very small babies. While we embrace this trend, we also have
to spend the time, as Dr Hanley suggested, to develop new
cannulas and new techniques so that eventually we can safe-
ly avoid circulatory arrest in all patients. 
Your technique involves transfer of the aortic cannula from
the pulmonary artery to the shunt. This introduces the possi-
bility of air embolization to the brain. Can you describe more
precisely how you avoid air into the shunt, because you have
to stop the circulation to transfer the cannula?
Dr Pigula. It is just another technical feature. A 3.5-mm
polytetrafluoroethylene shunt will accept an 8F or 10F Bio-
Medicus cannula. We carefully deair it by deairing the can-
nula and the shunt. Then, before opening the shunt, we just
temporarily occlude the right common carotid artery, so
even if there is any residual air left in the circuit, it will be
directed down the right subclavian artery rather than to the
brain.
To address your other concerns, which I share, I would
argue that the longer and the more complex the aortic con-
struction and the longer the potential for circulatory arrest,
the better off you are with some form of support. With con-
tinued support you do not have the time constraints that you
may have during circulatory arrest conditions, and your tech-
nical outcome may be better for that reason. 
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